Amicus Therapeutics inc (FOLD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access FOLD Annual Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Amicus Therapeutics inc's financial structure and capital allocation.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Assets
Cash & cash equivalent214.01
Marketable Securities, Current SH79.53
Cash & Short-term Investments293.00
Accounts receivable115.31
Inventories228.82
Prepaid Expense And Other Assets Current38.51
Total Current Assets676.17
Equipment/Property/Plant Net27.11
Goodwill net197.80
Intangible Assets13.92
Other Assets, Noncurrent34.88
Total Assets949.87
Liabilities
Accounts Payable, Current AC28.63
Accrued Liabilities And Other Liabilities200.46
Other Liabilities, Current8.74
Total Current Liabilities237.83
Long-term debt392.66
Total Long-term Debt392.66
Other liabilities, Noncurrent45.14
Total Liabilities675.63
Stockholders' Equity
Common Stock Value3.04
Additional Paid In Capital Common Stock3,014.46
Retained Earnings / Accumulated Deficit-2,767.29
Defined Benefit Plan and Other0.00
Other Equity24.04
Common Stockholder's Equity274.24
Total Stockholder's Equity274.24
Liabilities & Stockholder's Equity949.87
4 historic quarters locked

Sign in to unlock the full Amicus Therapeutics inc balance sheet history.

About Amicus Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001178879-25-000015

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.